Dealmaking in healthcare finance.
Asset management firm 360 ONE is expected to provide approximately ₹600 crore in financing to facilitate a stake buyback by the founder of AIMS (Asian Institute of Medical Sciences). The shares will be repurchased from British International Investment (BII) and OrbiMed, which currently hold stakes in AIMS’ parent entity, Blue Sapphire Healthcare.
The deal between 360 ONE and Blue Sapphire Healthcare is anticipated to be finalized within the coming weeks, according to sources familiar with the matter. This transaction underscores continued activity in the healthcare sector, with financial institutions playing a crucial role in facilitating ownership restructuring.
The financing will enable the AIMS founder to consolidate control of the company by acquiring the shares held by BII and OrbiMed, potentially paving the way for future strategic initiatives or expansion plans. Further details regarding the terms of the deal have not been disclosed.
About the Author
